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Abstract A case of visual hallucination, headache and left
hemiparesis is reported. The patient had a history of
recurrent attacks of similar semiology for the previous
15 years. MRI brain revealed a cortical hyperintensity on
T2W, FLAIR and diffusion weighted imaging (DWI) in the
right cerebral hemisphere with a normal ADC (apparent
diffusion coefficient) map and MR angiogram. Detailed
workup for MELAS was negative. A diagnosis of sporadic
hemiplegic migraine was made and he was managed con-
servatively. He made a gradual complete recovery over
2 weeks. He was discharged on flunarizine for prophylaxis
and has remained asymptomatic over the ensuing 4 months.
This interesting condition is reviewed and discussed herein.
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Introduction
Sporadic hemiplegic migraine is a rare subtype of migraine
headache with aura defined as migraine attacks associated
with some degree of motor weakness/hemiparesis during
the aura phase and where no first- or second-degree relative
(parent, sibling or child) has identical attacks [1]. The
earliest description of this syndrome has been by Whitty
et al. [2] in 1953. Bradshaw et al. in 1965 reported a series
of 37 cases of hemiplegic migraine. However, not all
patients in the series had recurrent episodes of hemiplegia
[4]. Thomsen et al. [3] reported a population search based
prevalence study in Denmark, which found 105 patients
with sporadic hemiplegic migraine at a prevalence rate of
0.01%. Based on their findings, sporadic hemiplegic
migraine was assigned a separate subtype in the revised
ICHD 2004, [1] with nearly 200 cases described so far, still
there is sparse data regarding the radiologic findings,
pathophysiology and treatment of acute attack as well as
prevention of SHM. We describe here the clinical and
radiologic findings in a patient with sporadic hemiplegic
migraine.
Case summary
A 30-year-old male presented to us with a history of
headache and left hemiparesis of 2-day duration. For about
half an hour preceding the headache, he had experienced
bright flashes of light in both his visual fields, which was
followed by severe throbbing headache accompanied by
photophobia, nausea and vomiting. Later, he became dis-
oriented, confused and developed weakness of his left upper
and lower limbs along with slurring of speech and difficulty
in swallowing. There was no history of fever, trauma, sei-
zure, or dehydration preceding the episode. In the past
16 years, he had had about 50 such episodes, starting at the
age of 14 years. Most of these attacks were preceded by
visualizing unformed flashes of light associated with black
spots and a feeling of objects revolving and shimmering,
making him feel as if he was on a giant wheel. This would
be associated with a feeling of numbness involving the right
arm and ascending up to his face in a peri-oral distribution.
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He also complained a sensation of objects crawling over his
four limbs. This would be followed by intense headache and
right sided weakness lasting 10–30 h. Twice in the pre-
ceding 4 years he had had experienced prolonged episodes
of right upper and lower limb weakness associated with
confusion and difficulty in speaking. In all other episodes,
he would recover spontaneously and completely within
10–12 h. He was thought to have complex partial seizures
and was being treated with carbamazepine in a dose of
900 mg/day without any benefit. He had no history to
suggest myoclonus, proximal muscle weakness, syncopal
attacks, cardiac disease, coagulation disorder, connective
tissue disease, hypertension, diabetes mellitus, smoking,
alcoholism or any recreational drug abuse. There was no
history of similar complaints in any of his family members
as ascertained by personal interview and examination of all
his first- and second-degree relatives. General physical
examination and examination of chest, cardiovascular and
abdomen was unremarkable. On nervous system exami-
nation, he was drowsy and disoriented to time, place and
person. He had a bilateral asymmetric sixth nerve palsy
(left [ right) and a left homonymous hemianopia. Fundus
examination was normal. There was a left hemiparesis with
a power of MRC grade 3/5 in his left upper and lower limbs
and suggestion of a left hemineglect. His hemogram,
coagulation profile, liver and renal functions, serum lip-
ids, homocystiene, CPK, thyroid function, tests for pro-
thrombotic state (protein C, S, anti-thrombin-3, factor V
Leiden mutation, anti-phospholipid antibodies and lupus
anticoagulant assay) and serum lactate were normal. His CT
head revealed fullness of gyri on the right side involving the
parieto-occipital region with no enhancement post contrast.
MRI brain performed at 18 h of onset of attack revealed
right cerebral hemisphere sulcal effacement and cortical
prominence which was hyperintense on T2, FLAIR and
DWI images with no abnormality on the ADC map bilat-
erally (Fig. 1a–e). Intracranial as well as extracranial MR
angiography was normal. His echocardiogram was normal.
His electroencephalogram revealed a generalized intermit-
tent theta slowing without any epileptiform discharges. His
CSF was acellular and protein, sugar and lactate levels were
normal. His muscle biopsy did not reveal any abnormality.
Genetic analysis for mitochondrial mutations MELAS
A 3243 G, MELAS T 3271 C, MELAS 3291 C and MERRF
A 8344 G (for MELAS) was negative.
He was managed conservatively and made a gradual and
complete recovery over the next 10 days. Flunarizine in a
dose of 10 mg per day was started for migraine prophylaxis
and he did not have any further episodes of headaches or
focal deficit over a 4-month follow-up. MRI study repeated
after 4 weeks of symptom onset showed resolution of
changes (Fig. 1f–h).
Discussion
Our patient had a history of visual and sensory symp-
toms accompanied by throbbing diffuse headaches and
Fig 1 (a) T1-weighted axial MRI brain, reveals right cerebral
hemispheric sulcal effacement and cortical thickening which is
hyperintense on T2WI (b), FLAIR (c) and DWI (d) images. There is
no evidence of altered signal on ADC map (e). Follow-up MR at
4 weeks shows resolution of changes (f–h)
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associated hemiparesis. He did not have any migrainous
headaches without aura separate from these episodes. None
of his family members had experienced similar symptoms.
The possible etiology of such a presentation could be any
of the causes listed in Table 1. However, during epilepsy
and TIA the symptoms generally do not have a gradual
progression and are not associated with severe and pro-
longed post-ictal headache phase. In the present case,
extensive work up as delineated above did not suggest the
possibility of a stroke or epilepsy. MELAS presents with
episodes of migrainous headaches and stroke-like focal
deficits associated with increased lactate in serum and CSF
during the attack. MRI brain often reveals T2 and FLAIR
hyperintense lesions predominantly in the posterior cere-
bral cortex. Genetic testing for appropriate mitochondrial
mutations and muscle biopsy with cytochrome oxidase
staining and electron microscopy is generally diagnostic
of this syndrome and was negative in our case. Pseudo-
migraine with lymphocytic pleocytosis and transient
neurologic deficits is a very rare condition associated with
single or multiple attacks of migraine—like headaches,
weakness, sensory and visual auras with confusion and
sometimes meningismus lasting minutes to hours. Typi-
cally, these patients have CSF lymphocytic pleocytosis
(10–760 cells/mm3) without elevation in protein or reduc-
tion in CSF glucose and have a normal brain imaging.
However, in this syndrome, visual auras are very uncom-
mon (12%) as compared to sensory symptoms (78%). Our
patient had neither CSF abnormality nor any evidence of
meningitis. The diagnosis of basilar migraine requires that
there should be no motor weakness as a part of the aura.
Although there was presence of other symptoms, the
presence of hemiplegia would argue against this diagnosis
in the present case. Migrainous infarction implies devel-
opment of a stroke during the course of a migraine attack.
It generally involves a large artery territory and corre-
sponds to the side of the origin of migrainous auras in the
previous attacks. Its diagnosis requires the presence of
prolonged hemiparesis associated with an MRI evidence of
infarction. In the present case, the MRI revealed evidence
of diffusion abnormality not involving any specific
vascular territory with normal ADC and resolution at
follow-up. Prolonged aura without infarction is defined as
prolonged aura with symptoms and signs lasting more than
2 weeks without any radiologic evidence of infarction. Our
patient fulfilled all criteria and best fits in the diagnosis of
Migraine with aura and its subtype of sporadic hemiplegic
migraine (ICHD criteria 1.2) [1, 3].
Most patients with sporadic hemiplegic migraine have
‘typical’ aura symptoms (visual, sensory and/or aphasic)
associated with motor weakness during the acute attack
[3, 4]. About three-fourth of patients with sporadic hemi-
plegic migraine also fulfill the criteria for basilar-type
migraine during the acute attack, but all such patients
should be diagnosed as hemiplegic migraine rather than
basilar-type migraine as per ICHD criteria [1, 3]. The auras
are more prolonged in sporadic hemiplegic migraine as
compared to a typical migraine with aura [3]. The acute
hemiplegic attack is always associated with severe head-
ache while typical migraine with aura may occur without
headache also [1, 3]. Absence of infarction on imaging
helps in differentiating it from migrainous infarction or
stroke associated with migraine [1, 3].
The data on imaging abnormalities described in sporadic
hemiplegic migraine as well as familial hemiplegic
migraine is sparse. The findings described consist of either
restricted diffusion, normal or increased diffusion based on
DWI and ADC values involving a hemisphere opposite to
the side of deficit [5–7] associated with normal T2W, T1W
images, angiography and perfusion studies have shown
hyperperfusion [5]. Magnetic resonance spectroscopy has
suggested reduced myoinositol/creatinine ratio, reduced
N-acetylaspartate (NAA) on the affected side with normal
choline/creatinine ratio. All these abnormalities have been
found to be resolving gradually over 4–12 weeks [5]. These
findings have been thought to represent a fully resolving
diffusion metabolic abnormality without any vaso-occlu-
sion, which could be due to the pathology at the cellular
level. The restricted diffusion is correlated with cell swell-
ing as a result of ATPase pump dysfunction [5, 7]. Similarity
of imaging findings in sporadic and familial hemiplegic
migraine is suggestive of a possible common pathophysi-
ology involving both the conditions which at present is
thought to be due to a spreading depolarizing wave of neuro-
electric or metabolic stimulus leading to prolonged neuronal
depolarization. Interestingly, however, in the present case,
the abnormality was in the form of hyperintense signal
apparent on T2W and FLAIR imaging also, with hyperin-
tense signal on DWI but no abnormalities on ADC map.
These changes could possibly suggest vasogenic edema or a
Table 1 Possible differential diagnosis of recurrent hemiplegia
1 Transient ischemic attacks and recurrent strokes
2 Complex partial seizure with and without secondary
generalization (with post-ictal Todd’s palsy)
3 One of the migraine with aura subtypes:
(a) Hemiplegic migraine.(sporadic or familial)
(b) Basilar-type migraine
(c) Migrainous infarction (complication of migraine)
4 Mitochondrial encephalopathy with lactic acidosis
and stroke-like episodes (MELAS) syndrome
5 Pseudomigraine with lymphocytic pleocytosis
with transient neurologic deficits
6 Alternating hemiplegia of childhood
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metabolic change as evidenced by complete reversibility on
follow-up, both clinically and radiologically.
Treatment strategy at present is only on the basis of case
reports of effective treatment with Flunarizine, Naloxane
and Verapamil [8–10]. At present, SHM is treated on the
same lines as familial hemiplegic migraine. Sympathomi-
metic drugs like ergotamine derivatives and triptans are
avoided in acute attacks of hemiplegic migraine due to the
fear of vasospasm leading to permanent sequelae. Simi-
larly, beta-blockers are not used for prophylaxis in patients
with hemiplegic or basilar-type migraine for the risk of
prolonged aura or migrainous infarction. However, the
most important part in the management of hemiplegic
migraine, and especially in SHM, is that it is considered a
diagnosis of exclusion, only after a thorough workup for
other conditions has been carried out. At the same time, it
is also important to keep SHM as a possibility during
evaluation of patients with recurrent TIAs or epilepsy,
especially if there is a history of hemiplegic episodes,
which recover without any residual sequelae.
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